“REBOUND OBESITY AFTER GLP-1 AGONISTS DISCONTINUATION”. Global Journal of Public Health Medicine 7, no. 1 (July 22, 2025): 208–215. Accessed May 25, 2026. https://gjphm.org/index.php/gjphm/article/view/336.